---
schema_version: "secwatch.filing_event.v1"
accession: "0001753926-25-000604"
form_type: "8-K"
ticker: "LIPO"
cik: "0001347242"
company_name: "LIPELLA PHARMACEUTICALS INC."
filed_at: "2025-04-09T23:59:59+00:00"
generated_at: "2026-05-23T18:10:26.737283+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Lipella increases designated Series C preferred shares from 1,050,000 to 1,260,000

## Summary
- Filed Certificate of Amendment on April 8, 2025, increasing Series C Voting Convertible Preferred Stock designation from 1,050,000 to 1,260,000 shares.
- Amendment modifies existing Certificate of Designation, potentially altering voting or conversion rights of current holders.
- Change in authorized shares may indicate future financing or strategic moves by the company.

## SEC filing metadata
- accession: 0001753926-25-000604
- form_type: 8-K
- ticker: LIPO
- cik: 0001347242
- company_name: LIPELLA PHARMACEUTICALS INC.
- filed_at: 2025-04-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- confidence: high
- sec_items: 5.03, 3.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1347242/000175392625000604/0001753926-25-000604-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1347242/000175392625000604/g084766_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001753926-25-000604
- JSON: https://secwatch.observer/filing/0001753926-25-000604.json
- Plain text: https://secwatch.observer/filing/0001753926-25-000604.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.